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To account for potential selection factors in the observed relation-
ship between Medicare Part D coverage and prescription drug use, 
this study uses data from the 2010 and 2012 waves of the Health 
and Retirement Study (HRS) to first examine the determinants of 
Medicare Part D enrollment, paying particular attention to the role 
of functional health status on the enrollment decision. Next, the 
study assesses whether and to what extent Medicare Part D cover-
age moderates the effect of functional health status on prescription 
drug use and monthly out-of-pocket spending among older adults. 
As prior studies indicate, the findings reveal that individuals who 
take up Medicare Part D have poorer (functional) health relative 
to nonparticipants, and thus, exhibit greater demand for prescrip-
tion drugs. Taking functional health status into account, Medicare 
Part D coverage is significantly associated with greater prescrip-
tion drug use among those with few health limitations, and is also 
significantly associated with greater out-of-pocket spending among 
those with the most health limitations. Thus, while prior studies 
have compared Medicare eligible- to non-eligible individuals to 
find that Medicare Part D coverage significantly lowers out-of-
pocket costs, and therefore, increases prescription drug use, this 
study compared Medicare Part D enrollees to eligible non-enrollees 
to generate findings that imply that the presumed effect of Medi-
care Part D coverage on prescription drug use may be spurious. In 
turn, advocacy efforts may be best directed at ensuring that the ex-
isting coverage gaps in Medicare Part D are continually addressed.
Key words: health insurance, access to and utilization of services, 
health care policy 
In the current climate of massive health care reform in 
the U.S., older adults potentially enjoy greater access to 
both prescription drug insurance and to use of prescription 
drugs. Before health care reform, however, access to both 
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prescription drug insurance and medications was not so 
readily available. Researchers estimate that just prior to imple-
mentation of the Medicare prescription drug benefit program 
(Medicare Part D), approximately one quarter of individuals 
age 65 and over lacked prescription drug insurance cover-
age (Levy & Weir, 2009). Meanwhile, prescription drug use 
among older adults had been steadily increasing even before 
passage and implementation of the Medicare Part D program. 
According to estimates released by the Center for Disease 
Control, the rate of prescription drug use among individuals 
65 years and over (i.e., the percent of individuals with at least 
one prescription drug in the past 30 days) had increased from 
73.6% in 1994 to 84.7% by the year 2002 (Center for Disease 
Control, 2014). 
Generally speaking, health service use, including the use of 
prescription drugs, should increase with greater health insur-
ance coverage (Hurd & McGarry, 1997). So the increase in pre-
scription drug use prior to implementation of Medicare Part 
D in 2006 may have reflected a combination of greater private 
insurance coverage, along with other factors such as a sicker 
older adult population, improvements in medicine, and/or 
more effective marketing by pharmaceutical companies.  
Nevertheless, Congress responded to the lack of prescrip-
tion drug insurance coverage (along with the increased demand 
for prescription drugs) among older adults by passing the 
Medicare Prescription Drug Improvement and Modernization 
Act, which established and implemented the Medicare Part 
D program effective January 1, 2006 to increase access to pre-
scription drugs among older adults (House Committee on 
Ways and Means, 2014). With the new program in place, the 
vast majority of eligible retirees were now covered under some 
form of prescription drug insurance plan. Thus, by 2010, 89.7% 
of all individuals 65 years and over reported using prescrip-
tion drugs (Center for Disease Control, 2014).  
Prior research on the impact of the Medicare prescription 
drug benefit program on prescription drug use among older 
adults has found that Medicare Part D initially lowered out-
of-pocket costs and therefore increased overall use in the early 
years of the program (Lichtenberg & Sun, 2007; Yin, Basu, 
Zhang, Rabbani, Meltzer, & Alexander, 2008). These studies 
generally rely on quasi-experimental designs to compare 
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out-of-pocket costs and rates of use between Medicare Part D 
eligible- and non-eligible individuals to show that there was 
indeed a program effect. 
What is not entirely clear from the favorable findings gen-
erated by these studies, however, is whether the observed re-
lationship between Medicare Part D coverage and prescription 
drug use and costs is attributable to potential selection factors 
that may be confounded for a program effect. To wit, studies 
examining the factors associated with the initial decision to 
enroll in Medicare Part D find that Part D enrollees are sicker, 
are more likely to use prescription drugs, and have higher out-
of-pocket spending than those who remain without any pre-
scription drug insurance coverage (Levy & Weir, 2010). Stated 
differently, the findings suggest selection into Part D that is 
based almost entirely on health status and use of prescription 
drugs (Levy & Weir, 2010).
To account for these potential selection factors in the ob-
served relationship between Medicare Part D coverage and 
prescription drug use, this study uses data from the 2010 and 
2012 waves of the Health and Retirement Study (HRS) to first 
examine the determinants of Medicare Part D enrollment, 
paying particular attention to the role of functional health 
status on the enrollment decision. Next, the study assesses 
whether and to what extent Medicare Part D coverage moder-
ates the effect of health status on prescription drug use and 
monthly out-of-pocket spending among older adults. 
Studies assessing the impact of public programs on health 
service use are especially important in the current climate 
of U.S. health care reform, as they provide evidence (or lack 
thereof) of the extent to which our public policies are effec-
tuating the legislative goals of our new public health care 
system. With this in mind, the current research extends prior 
work on the topic by explicitly taking into account possible 
selection factors that may be interacting with program effects. 
Moreover, the research uses the most recently available data 
from a nationally representative sample of older adults, and 
thus updates prior work that had relied on regional pharmacy 
chain data. And in lieu of a quasi-experimental design, this re-
search uses multivariate analyses to first identify the ways in 
which Medicare Part D enrollees are systematically different, 
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if at all, from non-enrollees, and second, to assess the extent to 
which the presumed effect of Medicare Part D differs across 
varying levels of functional health.    
The Literature and Conceptual Framework
Most studies that examine the determinants of health 
service use among older adults are framed around the 
Andersen Model (1968) which originally describes three sets 
of factors that predict health service use: predisposing char-
acteristics, enabling resources, and need. Predisposing factors 
include basic socio-demographic characteristics such as age, 
gender, race/ethnicity, and marital status. Enabling factors 
include both personal and community-level resources such as 
income, health insurance, and the availability of health person-
nel and facilities. Need refers to both perceived and evaluated 
need, that is, the individual’s perception of care requirements 
and professional judgment about the individual’s health status 
and his or her need for medical care (Andersen, 1995). In short, 
the model suggests that people’s use of health services is a 
function of their predisposition to use services, factors which 
enable or impede use, and their need for care (Andersen, 1995).
A major goal of the Andersen Model, as originally conceived, 
was to provide measures of access to medical care (Andersen, 
1995). Equitable access then, according to Andersen, occurs 
when demographic and need variables account for most of the 
variance in utilization (1995). As such, the Andersen Model is a 
useful framework not only to organize potential explanations 
for prescription drug use but also to gauge potential inadequa-
cies and inequities in access to prescription drug use.
Of particular interest in this research are factors related 
to need and enabling resources, and more specifically, func-
tional limitations and Medicare prescription drug insurance 
coverage. Need is a dimension that has arguably been over-
looked in prior research on prescription drug use among 
older adults, primarily due to the use of quasi-experimental 
designs that focus specifically on the enabling dimension, i.e., 
the treatment effects of Medicare prescription drug insurance 
coverage (Lichtenberg & Sun, 2007; Yin et al., 2008). In the 
broader context of health service use, however, need, i.e., per-
ceived, diagnosed, and functional health status, represents a 
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potentially powerful selection factor that may be relevant in 
the use of health services, including prescription drugs (Hurd 
& McGarry, 1997). Need is also important to consider since it 
implicates the issue of equity in access to health services and 
prescription drugs (Anderson, 1995). 
While the dimension of need may have previously taken 
on a secondary focus to the effect of enabling resources, i.e., 
prescription drug insurance coverage, in the context of policy 
studies on prescription drug use, it has nevertheless been rec-
ognized as a significant, contributing factor in other relevant 
contexts (Levy & Weir, 2010). In Levy and Weir (2010), the 
researchers used data from the 2002 through the 2006 waves 
of the Health and Retirement Study to estimate a model of 
Medicare Part D enrollment among those with no prior drug 
coverage and found that demand for prescription drugs, as 
measured by the number of diagnosed health conditions, was 
the most important determinant of the decision to enroll in the 
program. Stated differently, what this study showed was that 
Medicare Part D enrollees are sicker than those who do not 
enroll, thus suggesting that in the realm of access to health in-
surance, those who may need prescription drugs the most do 
appear to have access to Medicare prescription drug insurance 
coverage.
Meanwhile, studies examining the association between en-
abling resources and the use of prescription drugs have made 
a strong case for the favorable impact of prescription drug 
insurance coverage on prescription drug use (Lichtenberg 
& Sun, 2007; Yin et al., 2008). In one study investigating the 
effect of the Medicare Part D prescription drug benefit on drug 
utilization and expenditures (Yin et al., 2008), the researchers 
estimated prescription utilization and out-of-pocket expendi-
tures attributable to Part D among a sample of persons eligible 
for the benefit, and found that average monthly drug utiliza-
tion increased 5.9 percent and out-of-pocket expenditures de-
creased by 13.1 percent. In another recent study examining the 
impact of Medicare Part D coverage on prescription drug use 
by older adults (Lichtenberg & Sun, 2007), the researchers used 
a difference-in-differences research design and estimated that 
Medicare Part D reduced user cost among older adults by 18.4 
percent and increased prescription drug use by 12.8 percent. 
In using quasi-experimental designs, these two studies 
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follow in the tradition of the RAND Health Insurance 
Experiment which randomly assigned individuals to health 
insurance plans that varied in deductibles and co-payments 
and found that those with the largest cost-sharing had sig-
nificantly lower health expenditures relative to those with no 
cost-sharing (Newhouse, 1993). The main difference, however, 
between the Rand experiment and more recent studies exam-
ining the impact of Medicare prescription drug insurance cov-
erage is that the latter studies did not randomly assign sample 
members into treatment and control conditions, but rather 
compared elderly to non-elderly (i.e., Part D eligible to non-
eligible) individuals. 
While comparing eligible to non-eligible persons may be 
a conventional method of assessing the impact of public pro-
grams on health service use (see Cutler & Gruber, 1996; Card & 
Shore-Sheppard, 2004), in the absence of random assignment, 
such a comparison may be vulnerable to confounding factors, 
most notably in the form of selection effects or systematic dif-
ferences between treatment and comparison groups that may 
be mistaken for a program effect.  
Thus, to account for the possibility that the established 
relationship between Medicare Part D coverage and prescrip-
tion drug use among older adults may be due to selection 
factors, this study first examines the determinants of Medicare 
Part D enrollment with an eye towards identifying systematic 
differences between Medicare Part D participants and non-
participants. Under the expectation that Medicare Part D par-
ticipants are indeed sicker than non-participants, the study 
then assesses whether and to what extent Medicare Part D 
coverage moderates the effect of health status on prescription 
drug use and costs. More specifically, the study uses the well-
established Katz index of Activities of Daily Living (ADL) to 
create three separate categories of functional health status to 
determine whether the effect of Medicare Part coverage differs 
across these three varying levels of functional health (Katz, 
Ford, Moskowitz, Jackson, & Jaffe, 1963; Katz, Downs, Cash, 
& Grotz, 1970).      
Data and Methods
Data come from the Health and Retirement Study (HRS), 
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a nationally representative panel study of persons age 50 and 
over and their spouses. Section N of the HRS survey, in par-
ticular, elicits detailed information about respondents’ pre-
scription drug insurance coverage, prescription drug use, out-
of-pocket expenses, and health conditions requiring the use of 
prescription drugs, and is thus well-suited for a study estimat-
ing the effects of health status and prescription drug insurance 
coverage on prescription drug use. The full HRS consists of 
six cohorts representing persons born before 1960 in the U.S., 
including those born between 1942 and 1947, i.e., the War Baby 
(WB) cohort.
The sample is drawn from the 2010 and 2012 waves of 
the HRS to make use of the most recently available data on 
Medicare Part D coverage. To ensure that all sample members 
are eligible for enrollment and use of Medicare Part D, the 
study draws individuals 65 years and over from the 2010 wave 
who report Medicare coverage in both 2010 and 2012. The HRS 
includes 8,985 individuals who satisfy these criteria. Baseline 
data on sample members are collected for 2010, while outcome 
data (i.e., Part D enrollment, and prescription drug use and 
out-of-pocket expenses) are collected for 2012. Any sample 
member with missing baseline or outcome data is dropped 
from the analysis. Thus, the final sample to be used for the 
analysis of Part D enrollment includes 8,456 individuals who 
are eligible to enroll in Medicare Part D, while the sample to 
be used for the analysis of prescription drug costs includes a 
subset of 6,316 individuals who report non-zero out-of-pocket 
spending on prescription drugs.
Key Measures  
This research focuses on three main outcomes: Medicare 
Part D enrollment, prescription drug use, and monthly out-
of-pocket expenses incurred in purchasing prescription drugs. 
Constructing an appropriate measure of Medicare Part D en-
rollment or coverage can be complicated, because individu-
als covered under Medicare Advantage may report cover-
age under Part D as well. With this in mind, there are at least 
seven different types of prescription drug insurance options 
that may be examined: Medicare Part D, Medicaid, Medicare 
Advantage, Medigap, employer coverage, other drug cover-
age, and no coverage. Medicare Advantage, Medigap, and 
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other drug coverage are collapsed into one insurance category 
for analysis. 
The key outcome data for this study come from Section N 
of the 2012 HRS, which contains detailed questions on both 
public and private health insurance coverage that can be used 
to construct the prescription drug insurance options outlined 
above. In the beginning of this section, the HRS asks respon-
dents a series of straightforward questions regarding public 
health insurance coverage. Individuals are asked whether they 
signed up for Medicare prescription drug coverage, whether 
they are currently covered under Medicaid, whether they 
receive their Medicare benefits through a Health Maintenance 
Organization (HMO), and whether the HMO covers or pro-
vides help with paying for prescription drugs. While the coding 
for the first two questions would seem straightforward, if a 
sample member reports that they receive their Medicare ben-
efits through an HMO and that the HMO covers prescription 
drugs, then the individual is coded as being covered under a 
Medicare Advantage plan.
With respect to private prescription drug insurance cover-
age, this later section of the survey asks respondents to iden-
tify up to three private insurance plans that provide health in-
surance coverage, whether the private plan in question helps 
pay for prescription drugs, and where the respondent pur-
chased the private plan. If a sample member reports that an 
identified private plan helps pay for prescription drugs and 
that the individual did not purchase the private plan directly 
from an insurance company, then the individual is coded as 
having employer coverage. If the respondent reports that an 
identified private plan helps pay for prescription drugs and 
that the individual purchased the private plan directly from 
an insurance company, then the individual is coded as having 
Medigap coverage.
Towards the end of Section N, respondents who report 
taking prescription medications regularly are asked whether 
the costs of their prescription medications have been com-
pletely covered, mostly covered, only partially covered, or 
not covered at all by insurance. Sample members who are not 
covered under any of the aforementioned types of prescription 
drug insurance, but who report that their prescription drugs 
are at least partially covered are coded as having other drug 
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coverage. And finally, those individuals not reporting any of 
the aforementioned types of coverage are coded as having no 
coverage.
In the second part of the analysis, the two main outcome 
variables capture whether or not an individual regularly uses 
prescription drugs and the logarithm of monthly out-of-pock-
et expenses incurred in purchasing prescription drugs. This 
focus on utilization and (log) expenses, respectively, is consis-
tent with prior studies on health service utilization that often 
employ a two-part model—one model to predict the proba-
bility or likelihood of any use, and a second model to predict 
the level of use (Diehr, 1999; also see Hurd & McGarry, 1997). 
In the sample, 90.9% report that they take prescription drugs 
regularly and 75.3% report that they incurred monthly out-of-
pocket expenses for prescription drugs. Only those reporting 
out-of-pocket expenses (i.e., the 75.3%) are included in the final 
analysis of monthly out-of-pocket costs.
Another critical piece of the final analytical model is the 
measure of functional health status, i.e., the Katz ADL index, 
which reports the number of difficulties with six activities of 
daily living (e.g., bathing, eating, dressing, grooming, getting 
in and out of bed, and using the toilet). Based on this index, 
this research classifies sample members into three mutually 
exclusive and exhaustive groups: those with 0 ADL difficul-
ties, those with 1 or 2 ADL difficulties, and those with 3 or 
more ADL difficulties. The use of the Katz index as a measure 
of health status is justified in the health and disability policy 
literature as being less susceptible to measurement and endo-
geneity problems (see Bound, Schoenbaum, Stinebrickner, & 
Waidmann, 1999) as well as for its clinical usefulness (see Katz 
et al., 1970).
This study also incorporates additional relevant factors 
regarding health needs, economic access, and predisposing 
characteristics that are aligned with Andersen’s conceptual 
framework outlined above. Also subsumed under the catego-
ry of health needs are a series of dummy variables indicating 
whether a doctor diagnosed the respondent as having a partic-
ular condition in the 2010 Wave. The eight included conditions 
are high blood pressure, diabetes, cancer, lung disease, heart 
disease, stroke, psychiatric issues, or arthritis in the current 
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wave. The economic access category includes information on 
family income (i.e., income less than or equal to 100% of the 
federal poverty line (FPL); income 101% to 200% of the FPL; 
and income greater than 200% of the FPL) and education (high 
school education or GED versus no high school education or 
GED). Finally, predisposing factors include dummy variables 
on gender (female versus not female), ethnicity (Hispanic 
versus not Hispanic), race (Black versus not Black), marital 
status (married or partnered versus not married or partnered), 
and a categorical age variable (65 to 74; 75 to 84; and 85 and 
older). 
Using the key variables constructed and prepared for anal-
ysis along with the aforementioned health, economic access, 
and predisposing variables, the analysis begins with a logistic 
regression model of Medicare Part D enrollment, paying par-
ticular attention to the role of health needs. This first model 
only includes individuals who report no health insurance 
coverage in 2010, and is used to account for potential selec-
tion factors in the previously observed relationship between 
Medicare Part D coverage and prescription drug use. In the 
second part of the analysis, a logistic regression model is used 
to assess the determinants of prescription drug use while an 
ordinary least squares (OLS) regression is used to assess the 
determinants of monthly prescription drug expenses. In both 
the analysis of Medicare Part D enrollment and the analysis of 
prescription drug use and costs, the sample weights that are 
provided in the HRS tracker file are used to control for possible 
design effects.  
While the research is fairly well established in asserting 
that Medicare Part D lowered out-of-pocket expenses and in-
creased prescription drug use at least in the fledgling years of 
the program, what is less clear is whether the favorable effect 
of Medicare Part D coverage holds regardless of an individ-
ual’s health status. Thus, this study uses interaction terms to 
investigate the possibility that the effect of Medicare prescrip-
tion drug insurance may not be the same across different levels 
of functional health.  
As such, the expectation is that Medicare Part D coverage 
should lower monthly out-of-pocket spending on prescription 
drugs and therefore increase prescription drug use, particu-
larly among older adults with the poorest functional health. 
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Table 1. Logistic regression coefficients, standard errors, and exp(B) 
for Medicare Part D enrollment
 Medicare Part D Enrollment
 B(SE) Exp(B)
Health Needs   
  Functional Limitations   
     0 ADLs [Reference] - -
     1 to 2 ADLs 1.228(.453)*** 3.416
     3 or more ADLs -0.134(.891) 0.875
  Diagnosed Conditions   
     High blood pressure 0.192(.222) 1.211
     Diabetes -0.169(.435) 0.844
     Cancer -0.725(.575) 0.484
     Lung disease -0.080(.416) 0.923
     Heart disease 0.647(.279)** 1.910
     Stroke 0.117(.416) 1.124
     Psychiatric 0.112(.348) 1.118
     Arthritis -0.501(.323) 0.606
Economic Access   
  0% to 100% of FPL 0.956(.522)* 2.601
  101% to 200% of FPL -0.385(.452) 0.681
  >200% of FPL [Reference] - -
  High school education or GED -0.569(.402) 0.566
Predisposing   
  Female 0.209(.382) 1.232
  Hispanic 0.055(.691) 1.056
  Black 0.375(.499) 1.454
  Married or partnered 0.307(.409) 1.359
  Age   
     65 to 74 years [Reference] - -
     75 to 84 years -0.049(.409) 0.953
     85 years and over -0.127(.560) 0.881
Constant -2.131(.622) 0.119
Log Likelihood -115.966
Number of observations 367
Notes: ***Significant at the .01 level; **Significant at the .05 level; *Significant at the 
.10 level
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Conversely, older adults reporting no functional difficulties 
should have little need for prescription drugs, rendering the 
impact of Medicare Part D coverage minimal at best.  
Results
Table 1 presents logit coefficients, standard errors, and the 
odds (exp(B)) of Medicare Part D enrollment from a logistic 
regression model examining the determinants of the enroll-
ment decision. Among the two sets of health-related measures, 
the model reveals that functional limitations and heart disease 
are significantly associated with the enrollment decision. More 
specifically, individuals with 1 to 2 ADL difficulties are more 
than three times as likely as those with 0 ADL difficulties to 
enroll in Medicare Part-D, while those with heart disease 
are nearly twice as likely to enroll in the program relative to 
those without heart disease, thus lending some credence to the 
notion that Medicare Part D enrollees may indeed be sicker 
than non-enrollees. 
With respect to the economic access variables, the model 
reveals that family income as measured by an income-to-pov-
erty ratio is significantly associated with Medicare Part D en-
rollment. Individuals with family income less than or equal to 
100% of federal poverty are more than two and one-half times 
as likely to enroll in Part D relative to those with family income 
greater than 200% of poverty. Stated differently, it appears that 
Medicare Part D enrollees may not only be sicker but also 
poorer relative to non-enrollees. Meanwhile, none of the pre-
disposing characteristics were found to be significantly associ-
ated with Medicare Part D enrollment.
Table 2 presents logit coefficients, standard errors, and 
the odds of prescription drug use, as well as ordinary least 
squares (OLS) estimates and standard errors of the loga-
rithm of monthly out-of-pocket drug expenses. The models 
examine the extent to which the effect of Medicare prescrip-
tion drug insurance coverage on prescription drug use and 
costs differs across functional health status, and finds that 
among individuals with 0 ADL difficulties, stand-alone Part 
D coverage is significantly associated with 4.29 times greater 
odds of prescription drug use. Among those with 1 to 2 
ADL difficulties, stand-alone Part D coverage is significantly 
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associated with nearly 6 times greater odds of prescription 
drug use. Interestingly, stand-alone Part D coverage is not sig-
nificantly associated with prescription drug use among those 
with 3 or more ADL difficulties. This may be due to the financ-
ing structure built into the Part D program, that is, the co-in-
surance payments and coverage gaps (i.e., the donut hole) that 
incentivize enrollees to either minimize annual drug costs or 
claim catastrophic needs. 
Table 2a. Logistic and OLS Regression Coefficients and Standard 
Errors for Rx Drug Use and (log) Out-of-pocket Expenses
Logistic Regression of 
Rx Drug Use
OLS 
Regression 
of (Log) 
Out-of-Pocket 
Expenses
B(SE) Exp(B) B(SE)
Health Needs
 Functional Limitations and Prescription 
 Drug Insurance    
   0 ADLs | Employer 1.289(.252)*** 3.627 -0.015(.130)
   0 ADLs | Medicaid 1.098(.443)** 2.997 -0.674(.188)***
   0 ADLs | Stand-Alone Part D 1.456(.265)*** 4.290 0.167(.132)
   0 ADLs | Medicare Adv/Medigap/Other 1.234(.247)*** 3.437 -0.089(.130)
   1 – 2 ADLs | Employer 1.427(.518)*** 4.166 0.139(.170)
   1 – 2 ADLs | Medicaid 1.437(.825)* 4.208 -0.479(.262)*
   1 – 2 ADLs | Stand-Alone Part D 1.779(.667)*** 5.923 0.276(.176)
   1 – 2 ADLs | Medicare Adv/Medigap/Other 1.531(.460)*** 4.621 0.202(.165)
    3 ADLs | Employer 1.585(1.015) 4.878 0.210(.251)
    3 ADLs | Medicaid 2.805(1.540)* 16.529 -0.387(.294)
    3 ADLs | Stand-Alone Part D 1.367(.998) 3.924 0.513(.267)*
    3 ADLs | Medicare Adv/Medigap/Other 2.808(1.179)** 16.576 0.456(.220)**
 Diagnosed Conditions    
   High blood pressure 1.831(.154)** 6.243 0.114(.040)***
   Diabetes 1.418(.285)** 4.129 0.199(.042)***
   Cancer 0.268(.168) 1.308 -0.043(.052)
   Lung disease 0.391(.227)* 1.478 0.158(.053)***
   Heart disease 1.385(.231)*** 3.994 0.198(.039)***
   Stroke 0.844(.429)** 2.325 0.167(.066)**
   Psychiatric 0.479(.190)** 1.614 0.104(.041)**
   Arthritis 0.060(.114) 1.062 0.060(.039)
Notes: ***Significant at the .01 level; **Significant at the .05 level; *Significant at the 
.10 level
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Moreover, individuals diagnosed with high blood pres-
sure, diabetes, heart disease, and stroke are more than twice as 
likely to use prescription drugs relative to those without these 
conditions. With respect to predisposing factors, females and 
married or partnered individuals are significantly more likely 
to use prescription drugs. Surprisingly, none of the economic 
access factors were found to be significantly associated with 
prescription drug use. 
Table 2b. Logistic and OLS Regression Coefficients and Standard 
Errors for Rx Drug Use and (log) Out-of-pocket Expenses
Logistic Regression of Rx 
Drug Use
OLS 
Regression 
of (Log) 
Out-of-Pocket 
Expenses
B(SE) Exp(B) B(SE)
Economic Access    
 Family Income    
   0% to 100% of FPL -0.166(.302) .847 -0.167(.108)
   101% to 200% of FPL -0.006(.187) .994 -0.044(.061)
   >200% of FPL [Reference] - -  
 High school education or GED 0.262(.198) 1.299 -0.009(.068)
Predisposing    
 Female 0.375(.145)*** 1.454 0.021(.050)
 Hispanic -0.086(.329) .918 0.028(.116)
 Black -0.322(.284) .725 0.101(.097)
 Married or partnered 0.262(.154)* 1.300 0.133(.053)**
 Age    
     65 to 74 years [Reference] - -  
     75 to 84 years 0.144(.158) 1.155 0.061(.052)
     85 years and over 0.396(.272) 1.485 -0.038(.081)
Constant -1.125(.329) .325 3.247(.154)
Log Likelihood -732.069 -
R Square - 0.076
Number of observations 8456 6316
Notes: ***Significant at the .01 level; **Significant at the .05 level; *Significant at the 
.10 level
In the final OLS regression, the findings reveal that, sur-
prisingly, Medicare prescription drug insurance coverage 
bears little relation to out-of-pocket spending on prescrip-
tion drugs. While Medicaid coverage appears to be signifi-
cantly associated with lower out-of-pocket spending for 
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individuals with either 0 or 1 to 2 ADL difficulties, stand-alone 
Part D coverage is found to be significantly associated with 
greater out-of-pocket spending on prescription drugs among 
individuals with 3 or more ADL difficulties. Thus, while prior 
studies have linked Medicare Part D coverage to lower pre-
scription drug costs, and therefore, to increases in prescription 
drug use, these findings suggest a rather glaring disconnect 
in the effect of Medicare Part D coverage on prescription drug 
use and costs. 
Moreover and as one might expect, individuals diagnosed 
with high blood pressure, diabetes, lung disease, heart disease, 
stroke, and psychiatric conditions incur greater monthly out-
of-pocket expenses for prescription drugs relative to those 
without such conditions. More specifically, monthly out-of-
pocket expenses are in the range of 10.4% to 19.9% greater for 
those with the aforementioned diagnosed conditions. 
With respect to predisposing factors, out-of-pocket expens-
es are 13.3% higher for individuals who are married or part-
nered. And, as was the case for prescription drug use, none 
of the economic access factors were found to be significantly 
associated with the level of out-of-pocket spending.
Discussion
This research first examined the determinants of Medicare 
Part D enrollment with the expectation that Medicare Part D 
participants have poorer functional health relative to nonpar-
ticipants. The research then assessed whether and to what 
extent Medicare Part D coverage moderates the impact of 
functional health status on prescription drug use and costs. 
While prior studies have used quasi-experimental designs 
comparing Medicare eligible- to non-eligible (i.e., younger 
than age 65) individuals to assess the impact of Medicare Part 
D coverage on prescription drug use and costs, this research 
relied on multivariate regression analyses to assess the impact 
of Medicare Part D coverage within a sample of Part D eligible 
older adults and across varying levels of functional health. 
As such, logistic regression analyses first revealed that 
Medicare Part D participants are systematically different from 
nonparticipants in a number of important ways. As prior 
studies have shown (Levy & Weir, 2010), individuals who enroll 
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in Medicare Part D indeed have poorer (functional) health rel-
ative to nonparticipants, and thus, have greater demand for 
prescription drugs. The analyses also revealed that Medicare 
Part D participants tend to have the lowest income levels ac-
cording to federal poverty standards. That is, Medicare Part 
D participants likely use their Medicaid prescription drug in-
surance coverage to help pay for their Part D program ben-
efits. In short, Medicare Part D participants are sicker and 
poorer relative to nonparticipants. Stated differently, health 
and income represent potentially powerful selection factors in 
any observed relationship between Medicare Part D coverage 
and prescription drug use which may remain unaccounted for 
in research designs that do not allow for random assignment 
into treatment and control conditions for practical or ethical 
reasons.
Taking into consideration these prominent selection factors 
and functional health status in particular, logistic and OLS re-
gressions revealed that the effect of Medicare Part D coverage 
on prescription drug use and costs is not as unambiguous as 
previously believed. Clearly, Medicare Part D coverage is sig-
nificantly associated with prescription drug use and costs, but 
in a manner that likely reflects the financing structure of the 
Medicare Part D program. For those with few health limita-
tions, Medicare Part D coverage appears to have a negligible 
impact in lowering costs, and yet, enrollees are still more likely 
to use prescription drugs. For those with the most health limi-
tations, Medicare Part D coverage is significantly associated 
with greater out-of-pocket spending on prescription drugs, 
and hence, such enrollees are not significantly more likely to 
use prescription drugs. Stated differently, while prior studies 
have compared Medicare eligible- to non-eligible individu-
als to find that Medicare Part D coverage significantly lowers 
out-of-pocket costs, and therefore, increases prescription drug 
use, this study compared Medicare Part D enrollees to age-
eligible non-enrollees to generate findings that imply that the 
presumed effect of Medicare Part D coverage on prescription 
drug use may be spurious.
While the findings may seem somewhat counterintuitive, 
they are arguably consistent with the Medicare Part D financ-
ing structure and the coverage gaps that are inherent in the 
program. That is, individuals with the fewest health needs 
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may be incentivized to minimize their prescription drug use 
due to the deductibles and a significant coverage gap for 
annual prescription drug costs that reach moderate levels (i.e., 
the “doughnut hole”), while individuals with the most health 
needs may be incentivized to claim catastrophic benefits, par-
ticularly if their annual prescription drug costs fall within the 
doughnut hole.
Future research on prescription drug use among older 
adults might consider examining the impact of Medicare 
Part D coverage not only across varying levels of functional 
health but across varying levels of income. As shown above, 
Medicare Part D participants are not only sicker than nonpar-
ticipants but they also exhibit lower levels of income. Hence, 
it would be interesting to consider how selection factors other 
than health impact the use of prescription drugs and associat-
ed costs. Future research could also entertain the possibility of 
incorporating policy-relevant cutoffs in terms of annual (total) 
prescription drug costs if such data becomes available. This 
would be with an eye towards improving upon previously de-
veloped measures of the demand for prescription drugs (see 
Levy & Weir, 2009). In addition, with the implementation of 
the Affordable Care Act (ACA) provisions that gradually close 
the existing coverage gaps in prescription drug use and spend-
ing, it becomes almost imperative that this study is revisited 
after full implementation of ACA to see whether the differen-
tial impacts of Medicare Part D coverage across varying levels 
of functional health still hold.
While increasing access to prescription drug insurance 
coverage was not necessarily one of the prominent goals of 
the recent health care reform, implicit in the goal of expand-
ing access to health insurance coverage more broadly among 
previously uninsured individuals is that this greater access 
to health insurance will necessarily lead to greater access to 
health service use in its various forms. Thus, the findings 
generated by this research provide evidence that while older 
adults across the health spectrum seem to be benefiting from 
greater access to prescription drugs, this greater access is prob-
ably not attributable to the lowering of prescription drug costs 
vis-à-vis the Medicare prescription drug benefit program, as 
prior research on prescription drug use has assumed to be the 
case. Hence, policy advocates who champion greater access to 
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health insurance and care should note that current advocacy 
efforts in this realm may be best directed at ensuring that the 
existing coverage gaps in government-sponsored prescription 
drug plans are indeed continually addressed.   
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Appendix: Baseline Characteristics of Sample Members by 
Prescription Drug Insurance Coverage and Prescription Drug Use
Table A1 below describes the baseline characteristics of sample 
members by type of prescription drug insurance coverage in 2010. 
The columns represent five different prescription drug insurance 
options reported in the study. With respect to the number of 
functional limitations, sample members who report Stand-Alone 
Part D coverage are not different from those without prescription 
drug insurance coverage. While they appear to be no different 
in terms of their functional health, they are more likely to be 
diagnosed with high blood pressure (76% v. 60%), diabetes (28% v. 
17%), cancer (21% v. 17%), lung disease (15% v. 10%), heart disease 
(36% v. 29%), psychiatric conditions (19% v. 15%), and arthritis (79% 
v. 65%) relative to those without coverage. 
With respect to the economic access variables, sample members 
with Part D coverage are different from those without prescription 
drug insurance coverage both in terms of family income and 
educational attainment. They are less likely to be poor (7% vs. 10%) 
and more likely to have a high school education or GED (81% vs. 
77%) relative to those without coverage. 
As for predisposing characteristics, sample members with Part D 
coverage are less likely to be Hispanic and Black, and more likely to 
be female and married or partnered as compared to those without 
coverage. They are also generally younger relative to those without 
coverage. 
Table A2 below describes the baseline characteristics of sample 
members by prescription drug use in 2012. Sample members 
who report regularly using prescription drugs are reported 
under one column, while those who report not using prescription 
drugs regularly are reported under a separate column. Among 
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sample members with 0 ADL difficulties, those who regularly use 
prescription drugs are more likely to be covered under stand-alone 
Part D relative to those who do not use prescription drugs (21% v. 
18%). Among sample members with 1 to 2 ADL difficulties, only 
3% of those who regularly use prescription drugs have stand-
alone Part D coverage as compared to 1% for those who do not 
use prescription drugs. Among sample members with 3 or more 
ADL difficulties, there is no apparent difference in stand-alone Part 
D coverage between those who regularly use prescription drugs 
relative to those who do not use prescription drugs. 
Moreover, sample members who regularly use prescription drugs 
are more likely to be diagnosed with high blood pressure (79% v. 
25%), diabetes (31% v. 6%), cancer (21% v. 17%), lung disease (15% 
v. 7%), heart disease (38% v. 9%), stroke (11% v. 2%), psychiatric 
conditions (21% v. 8%), and arthritis (79% v. 64%) relative to those 
who do not use prescription drugs. They are also somewhat more 
likely to be female, Black, and married or partnered as compared to 
those who do not use prescription drugs.
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Table A1. Sample Characteristics by Prescription Drug Insurance Coverage in 2010
 Prescription Drug Insurance Coverage
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Health Needs       
  Functional Limitations       
    0 ADLs 0.84 0.60 0.83 0.81 0.83 0.81
    1 to 2 ADLs 0.12 0.23 0.12 0.14 0.13 0.14
    3 or more ADLs 0.04 0.17 0.05 0.05 0.05 0.05
  Diagnosed Conditions       
    High blood pressure 0.73 0.87 0.76 0.72 0.60 0.74
    Diabetes 0.28 0.42 0.28 0.27 0.17 0.29
    Cancer 0.23 0.16 0.21 0.21 0.17 0.21
    Lung disease 0.15 0.21 0.15 0.13 0.10 0.15
    Heart disease 0.35 0.45 0.36 0.35 0.29 0.36
    Stroke 0.11 0.17 0.10 0.09 0.09 0.10
    Psychiatric 0.20 0.35 0.19 0.19 0.15 0.20
    Arthritis 0.77 0.82 0.79 0.77 0.65 0.77
Economic Access       
  Family Income       
    0% to 100% of FPL 0.04 0.43 0.07 0.07 0.10 0.09
    101% to 200% of FPL 0.15 0.35 0.25 0.26 0.29 0.23
    >200% of FPL 0.81 0.22 0.68 0.67 0.60 0.68
  High school education or GED 0.88 0.40 0.81 0.78 0.77 0.79
Predisposing       
  Female 0.54 0.69 0.63 0.58 0.54 0.59
  Hispanic 0.04 0.33 0.05 0.10 0.07 0.09
  Black 0.12 0.33 0.10 0.12 0.13 0.13
  Married or partnered 0.68 0.31 0.60 0.62 0.55 0.60
  Age       
    65 to 74 years 0.52 0.48 0.53 0.52 0.49 0.52
    75 to 84 years 0.38 0.38 0.37 0.36 0.34 0.37
    85 years and over 0.10 0.14 0.10 0.12 0.17 0.11
       
Number of observations 2581 652 2105 2751 367 8456
184    Journal of Sociology & Social Welfare
Table A2. Sample Characteristics by Prescription Drug Use in 2012
 Prescription Drug Use
 
Rx 
Drug 
Use
No Rx 
Drug 
Use
Total
Health Needs    
  Functional Limitations & Prescription Drug  
  Insurance    
    0 ADLs | Employer 0.26 0.25 0.26
    0 ADLs | Medicaid 0.05 0.04 0.05
    0 ADLs | Stand-Alone Part D 0.21 0.18 0.21
    0 ADLs | Medicare Adv/Medigap/Other 0.26 0.30 0.26
    1 – 2 ADLs | Employer 0.04 0.02 0.04
    1 – 2 ADLs | Medicaid 0.02 0.01 0.02
    1 – 2 ADLs | Stand-Alone Part D 0.03 0.01 0.03
    1 – 2 ADLs | Medicare Adv/Medigap/Other 0.05 0.03 0.05
     3 ADLs | Employer 0.01 0.01 0.01
     3 ADLs | Medicaid 0.01 0.00 0.01
     3 ADLs | Stand-Alone Part D 0.01 0.01 0.01
     3 ADLs | Medicare Adv/Medigap/Other 0.02 0.01 0.02
  Diagnosed Conditions    
    High blood pressure 0.79 0.25 0.74
    Diabetes 0.31 0.06 0.29
    Cancer 0.21 0.17 0.21
    Lung disease 0.15 0.07 0.15
    Heart disease 0.38 0.09 0.36
    Stroke 0.11 0.02 0.10
    Psychiatric 0.21 0.08 0.20
    Arthritis 0.79 0.64 0.77
Economic Access    
  Family Income    
    0% to 100% of FPL 0.09 0.08 0.09
    101% to 200% of FPL 0.23 0.21 0.23
    >200% of FPL 0.68 0.70 0.68
  High school education or GED 0.79 0.79 0.79
Predisposing    
  Female 0.59 0.56 0.59
  Hispanic 0.09 0.08 0.09
  Black 0.13 0.11 0.13
  Married or partnered 0.61 0.59 0.60
  Age    
    65 to 74 years 0.51 0.56 0.52
    75 to 84 years 0.37 0.08 0.37
    85 years and over 0.12 0.11 0.11
Number of observations 7750 706 8456
